Higher Monomeric C-reactive Protein Levels Are Associated with Premature Coronary Artery Disease

Overview

Journal Front Immunol

Date 2025 Jan 27

PMID 39867895

Authors

Ivan Melnikov

Sergey Kozlov

Sergey Okhota

Olga Saburova

Yuliya Avtaeva

Tatiana Kuznetsova

Konstantin Guria

Lyudmila Prokofieva

Tatiana Riazantseva

Shang-Rong Ji

Yi Wu

Zufar Gabbasov

Affiliations

Soon will be listed here.

Abstract

Introduction: Chronic inflammation is a major risk factor for coronary artery disease (CAD). Currently, the inflammatory cardiovascular risk is assessed via C-reactive protein (CRP) levels measured using a high-sensitivity assay (hsCRP). Monomeric CRP (mCRP) is a locally produced form of CRP that has emerged as a potential biomarker of inflammation.

Aim: This study investigated whether mCRP levels are associated with premature CAD.

Materials And Methods: This study comprised 103 participants of both sexes, including 50 patients 56 ± 7 years old with premature CAD and 53 patients 51 ± 10 years old without CAD. CAD was verified using coronary angiography, hsCRP levels were measured using a standard assay, and mCRP levels were measured using fluorescent cytometric beads conjugated with an anti-mCRP antibody.

Results: The levels of hsCRP were 0.99 (0.59; 3.10) mg/L vs. 0.63 (0.35; 1.85) mg/L (p = 0.067), and mCRP 6.84 (4.20; 13.78) µg/L vs. 2.57 (0.32; 5.66) µg/L (p <0.001) in patients with CAD vs. patients without CAD, respectively. There was a weak positive correlation between the mCRP and hsCRP levels (ρ = 0.214; p = 0.030). hsCRP levels were below 2.0 mg/L (i.e., residual inflammatory cardiovascular risk should have been excluded) in 70% of patients with CAD and 79% of patients without CAD (p = 0.365). mCRP levels differed between the groups of patients with hsCRP levels below 2.0 mg/L: 5.14 (4.07; 10.68) µg/L vs. 2.77 (0.53; 5.00) µg/L in patients with or without CAD, respectively (p <0.001). Logistic regression analysis demonstrated that mCRP levels were independently associated with premature CAD. The adjusted odds ratio was 1.18 (95% CI 1.06-1.33, p = 0.004) per each µg/L increase in mCRP levels.

Conclusion: Higher mCRP levels were associated with premature CAD, independent of hsCRP levels and traditional risk factors.

References

Molins B, Pena E, de la Torre R, Badimon L . Monomeric C-reactive protein is prothrombotic and dissociates from circulating pentameric C-reactive protein on adhered activated platelets under flow. Cardiovasc Res. 2011; 92(2):328-37. DOI: 10.1093/cvr/cvr226. View

Zeitouni M, Clare R, Chiswell K, Abdulrahim J, Shah N, Pagidipati N . Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease. J Am Heart Assoc. 2020; 9(24):e017712. PMC: 7955368. DOI: 10.1161/JAHA.120.017712. View

Zhang Z, Na H, Gan Q, Tao Q, Alekseyev Y, Hu J . Monomeric C-reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype-dependent pattern: A risk factor for Alzheimer's disease?. Aging Cell. 2021; 20(11):e13501. PMC: 8590103. DOI: 10.1111/acel.13501. View

Soehnlein O, Libby P . Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021; 20(8):589-610. PMC: 8112476. DOI: 10.1038/s41573-021-00198-1. View

Libby P . Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells. 2021; 10(4). PMC: 8073599. DOI: 10.3390/cells10040951. View

Rajab I, Hart P, Potempa L . How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression. Front Immunol. 2020; 11:2126. PMC: 7511658. DOI: 10.3389/fimmu.2020.02126. View

Khreiss T, Jozsef L, Potempa L, Filep J . Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 2004; 109(16):2016-22. DOI: 10.1161/01.CIR.0000125527.41598.68. View

Li H, Wang J, Meng F, Jia Z, Su Y, Bai Q . An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein. J Biol Chem. 2016; 291(16):8795-804. PMC: 4861447. DOI: 10.1074/jbc.M115.695023. View

Fujita C, Sakurai Y, Yasuda Y, Homma R, Huang C, Fujita M . mCRP as a Biomarker of Adult-Onset Still's Disease: Quantification of mCRP by ELISA. Front Immunol. 2022; 13:938173. PMC: 9284222. DOI: 10.3389/fimmu.2022.938173. View

10.

Williams R, Moran J, Fryer A, Littlejohn J, Williams H, Greenhough T . Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an Dissociated Form of C-Reactive Protein. Front Immunol. 2020; 11:115. PMC: 7010908. DOI: 10.3389/fimmu.2020.00115. View

11.

Ridker P . Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis. Circ Res. 2019; 124(3):437-450. PMC: 6386195. DOI: 10.1161/CIRCRESAHA.118.313129. View

12.

Ji S, Wu Y, Zhu L, Potempa L, Sheng F, Lu W . Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J. 2006; 21(1):284-94. DOI: 10.1096/fj.06-6722com. View

13.

Wang J, Tang B, Liu X, Wu X, Wang H, Xu D . Increased monomeric CRP levels in acute myocardial infarction: a possible new and specific biomarker for diagnosis and severity assessment of disease. Atherosclerosis. 2015; 239(2):343-9. DOI: 10.1016/j.atherosclerosis.2015.01.024. View

14.

Gao N, Yuan P, Tang Z, Lei J, Yang Z, Ahmed M . Monomeric C-reactive protein is associated with severity and prognosis of decompensated hepatitis B cirrhosis. Front Immunol. 2024; 15:1407768. PMC: 11183496. DOI: 10.3389/fimmu.2024.1407768. View

15.

Kolb-Bachofen V, Egenhofer C . Expression of membrane-associated C-reactive protein by human monocytes: indications for a selectin-like activity participating in adhesion. Glycoconj J. 1995; 12(2):122-7. DOI: 10.1007/BF00731355. View

16.

Ullah N, Wu Y . Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity. Cell Biochem Biophys. 2022; 80(4):595-608. DOI: 10.1007/s12013-022-01089-x. View

17.

Garrido M, Bordagaray M, Schweitzer C, Lucero-Mora J, Reyes M, Pellegrini E . Reduced C-reactive protein levels after root canal treatment in clinically healthy young apical periodontitis individuals at cardiovascular risk. A prospective study. Int Endod J. 2024; 57(4):406-415. DOI: 10.1111/iej.14029. View

18.

Rhoads J, Lukens J, Wilhelm A, Moore J, Mendez-Fernandez Y, Kanneganti T . Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9. J Immunol. 2017; 198(5):2105-2114. PMC: 5318843. DOI: 10.4049/jimmunol.1601563. View

19.

Zha Z, Cheng Y, Cao L, Qian Y, Liu X, Guo Y . Monomeric CRP Aggravates Myocardial Injury After Myocardial Infarction by Polarizing the Macrophage to Pro-Inflammatory Phenotype Through JNK Signaling Pathway. J Inflamm Res. 2022; 14:7053-7064. PMC: 8703048. DOI: 10.2147/JIR.S316816. View

20.

Wu Y, Potempa L, El Kebir D, Filep J . C-reactive protein and inflammation: conformational changes affect function. Biol Chem. 2015; 396(11):1181-97. DOI: 10.1515/hsz-2015-0149. View